Neurological Medicine Centre

Telephone: 020-89168297, 020-89168096; address: Floors 10 and 11, Building 2. Department profile: The Department of Neurology of the Neuromedicine Center at Guangdong Second Provincial General Hospital is a National Advanced Stroke Center, a member institution of the China Stroke Center Alliance, a Neurointervention Fellowship and Training Base of the National Health Commission Center for Capacity Building and Continuing Education, the National Health Commission’s Neurointervention Construction Center, a subcenter of the National Clinical Research Center for Neurological Diseases, a network member institution of the National Clinical Research Center for Neurological Diseases, a Guangdong Provincial Clinical Key Specialty, the Neurointervention Training Center of the Guangdong Clinical Medicine Association, the chairperson’s institution for the Interventional Neurology Professional Committee of the Guangdong Clinical Medicine Association, a member institution of the Southern Central Nervous System Infection Alliance of Guangdong Second Provincial General Hospital, and a member institution of the Thrombosis and Thromboembolic Disease Prevention and Treatment Alliance of the Guangdong Hospital Association. The Department of Neurology is a comprehensive discipline integrating clinical care, teaching, and research. The hospital is equipped with a 5G image-transmission mobile CT vehicle, a digital subtraction angiography (DSA) system, a hybrid operating room, high-end spiral CT, 3.0 T MRI, and various other high-end devices. It can perform multiple technically demanding hybrid procedures and is committed to the diagnosis, treatment, and research of neurological diseases. The Department of Neurology has four wards: Neurology Ward 1 (Cerebrovascular Disease Center), Neurology Ward 2, the Neurological Intensive Care Unit (NICU), and the High-End Medical Ward; it has 124 authorized beds and 68 medical and nursing staff, including 14 staff members with senior professional titles, 3 doctoral supervisors, 1 master’s supervisor, 2 professionals who returned from overseas study, 1 postdoctoral fellow, 7 doctoral degree holders, and 10 master’s degree holders. Four subspecialty groups have been established: vascular diseases, neurocritical care, neuroimmunology and infectious diseases, and neurodegenerative diseases. The department has a neurological rehabilitation room, neuroelectrophysiology room, neuropsychological testing room, and dizziness and vestibular function examination room; it possesses advanced instruments including video EEG, sleep EEG, EMG, a brain reflex therapy device, a cerebral circulation therapy device, a transcranial magnetic stimulation device, a transcranial Doppler ultrasound device (TCD), ventilators, a central monitoring system, a fiber-optic bronchoscope, a blood gas analyzer, a hemofiltration machine, and a PiCCO monitor. It is a National Standardized Residency Training Base for Neurology, has received the First Prize in the Natural Science Award of the Ministry of Education and the Second Prize in the Guangdong Provincial Science and Technology Progress Award, and has received funding from multiple research grants at or above the provincial departmental level. It has published nearly 300 papers, including nearly 100 SCI papers in international journals such as Stroke and Neuroscience, and has published the monographs "Therapeutics of Cerebrovascular Disease with Integrated Traditional Chinese and Western Medicine" and "Dementia Therapeutics." It has participated in multicenter clinical collaborative research projects with Tiantan Hospital, the General Hospital of the Eastern Theater Command, Shengjing Hospital Affiliated with China Medical University, and many other hospitals. In 2023, it received recognition as an Outstanding Application Institution and Outstanding Subcenter in the National Clinical Research Center for Neurological Diseases’ "Precision Dual-Antiplatelet Action for Cerebrovascular Disease," won First Prize in the TRACE-III Project, and received Third Prize as an Outstanding Network Member Institution. The department organizes the "Ivy Action—Public-Welfare Stroke Screening, Prevention and Treatment Project," regularly conducts public-welfare stroke screening in communities, and has received the Silver Award in the China Youth Volunteer Service Project Competition and the Gold Award in the National Health and Wellness Industry Youth Volunteer Service Project Competition. At the same time, the department established the Ivy Stroke Prevention and Treatment Alliance, contributing to stroke prevention and treatment in primary-level hospitals. The department organizes an interventional thrombectomy training course every year, contributing to the improvement of neurointerventional technical proficiency in primary-level hospitals. In 2023, the Neuromedicine Center of Guangdong Second Provincial General Hospital was approved as the Neurointervention Fellowship and Training Base of the National Health Commission Center for Capacity Building and Continuing Education and can accept large numbers of visiting neurointerventional fellows and trainees. Meanwhile, with the help of its telemedicine system, the Department of Neurology connects with the team led by Academician Ji Xunming at the Beijing Institute for Brain Disorders and with Beijing Tiantan Hospital, providing remote outpatient and consultation services so that patients can consult renowned Beijing physicians without leaving home. Qu Hongying, President of Guangdong Second Provincial General Hospital, and Academician Ji Xunming of the Beijing Institute for Brain Disorders signed a cooperation agreement to jointly establish the Collaborative Innovation Center for Major Brain Diseases. The Stroke Center has distinctive strengths in emergency stroke care: 1. The acute stroke fast-track pathway is characterized by speed and precision. The median door-to-needle time (DNT) remains stable at 22 minutes, and one-stop head-and-neck CTA combined with head CTP provides rapid imaging in 8 minutes, providing precise guidance for subsequent bridging therapy with mechanical thrombectomy or endovascular perfusion. 2. The Stroke Center has comprehensive technical capabilities, including intravenous thrombolysis and mechanical thrombectomy for acute cerebral infarction, intracranial and extracranial arterial angioplasty, recanalization of chronically occluded vessels, embolization of intracranial aneurysms, embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas, embolization of carotid-cavernous fistulas, embolization of spinal arteriovenous malformations, carotid endarterectomy, hematoma evacuation and minimally invasive drainage for cerebral hemorrhage, intraoperative Doppler ultrasound vascular monitoring, artificial-intelligence-assisted technologies, and more. It can perform various hybrid procedures, mainly for complex cerebrospinal vascular diseases, such as giant intracranial aneurysms, cerebral arteriovenous malformations, and spinal vascular malformations. 3. The Stroke Center’s information-based quality-control infrastructure is at the forefront in Guangdong Province. 4. It has established regional influence: in 2019, it was approved as the Neurointervention Training Base of the Interventional Neurology Professional Committee of the Guangdong Clinical Medicine Association; in 2022, it was approved as a National Neurointervention Construction Center; in 2023, the Neuromedicine Center of Guangdong Second Provincial General Hospital was approved as the Neurointervention Fellowship and Training Base of the National Health Commission Center for Capacity Building and Continuing Education and can accept large numbers of interventional fellows and trainees every year. It regularly holds the Standardized Training Course for Interventional Neurology Specialists of the Neurointervention Special Committee of the Neurology Branch of the Chinese Medical Doctor Association and the annual academic meeting of the Interventional Neurology Special Committee of the Guangdong Clinical Medicine Association. 5. It is equipped with South China’s first emergency mobile CT vehicle. Its neurointerventional capabilities are comprehensive and are among the most advanced in China, particularly in ultra-early intra-arterial thrombolysis, thrombectomy, and intravenous–intra-arterial bridging thrombectomy therapy for cerebral infarction. Professor He Xuying performing a hybrid procedure for a patient with a spinal dural arteriovenous fistula. Department-wide group photograph. Address: No. 466 Xingang Middle Road, Haizhu District, Guangzhou; postal code: 510317; department telephone: 020-89168297, 020-89168096; 24-hour stroke emergency hotline: 020-89169999. Academic leader: He Xuying, Chief Physician. He serves as Director of the Neuromedicine Center of Guangdong Second Provincial General Hospital, Director of the Department of Neurology, and Director of the Cerebrovascular Disease Center; he holds a Doctor of Medicine degree, is a Chief Physician, and is a doctoral supervisor. He currently serves as Vice Chairperson of the Youth Committee for Neurointervention of the Chinese Medical Doctor Association, Standing Committee Member of the Cerebrovascular Disease Professional Committee of the Chinese Research Hospital Association, Chairperson of the Cerebrovascular Disease Management Branch of the Guangdong Medical Industry Association, Vice Chairperson of the Neurointervention Physicians Branch of the Guangdong Medical Doctor Association and Head of its Hemorrhage Specialty Group, Standing Committee Member of the Interventional Radiology Physicians Branch of the Guangdong Medical Doctor Association, Member of the Neurointervention Branch of the Chinese Stroke Association, and Member of the Youth Council of the Chinese Stroke Association. He has led multiple funded projects, including projects of the National Natural Science Foundation of China and Guangdong Provincial Science and Technology Plan projects. He is editor-in-chief of three monographs on cerebrovascular disease: "Practical Neurointerventional Radiology," "Practical Endovascular Therapy for Intracranial Aneurysms," and "Intracranial Arteriovenous Malformations." His SCI publications have a cumulative impact factor of 45.45, and he has received one Third Prize in the Chinese Medical Science and Technology Award. In 2018, he was named a Guangdong Outstanding Young Medical Talent; in 2019, he received the Pearl River Young Physician Award and was named a Yangcheng Good Doctor; in 2023, he received the Guangdong Physician Award. He specializes primarily in the interventional and surgical treatment of vascular diseases such as cerebral aneurysms, cerebral arteriovenous malformations, dural arteriovenous fistulas, carotid-cavernous fistulas, and spinal vascular lesions. He has mastered various internationally leading interventional treatment techniques for cerebrospinal vascular diseases, including flow-diverter stent implantation, covered stent implantation, transvenous embolization of cerebral arteriovenous malformations, and embolization of spinal arteriovenous malformations. He was the first physician in South China to serve as a mentor for flow-diverter stent implantation and pioneered in South China such nationally leading techniques as transvenous embolization of cerebral arteriovenous malformations. He performs nearly 1,000 procedures for intracranial and spinal vascular diseases every year. He was the first in China to develop an interventional training course using a cerebrovascular disease simulator, and 15 sessions have been held to date.